Edition:
United Kingdom

People: Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

162.44USD
7:37pm BST
Change (% chg)

$-0.02 (-0.01%)
Prev Close
$162.46
Open
$162.51
Day's High
$163.39
Day's Low
$162.07
Volume
257,722
Avg. Vol
681,043
52-wk High
$197.00
52-wk Low
$114.27

McDonnell, Peter 

Dr. Peter J. McDonnell, M.D. is Independent Director of Allergan Plc. Dr. McDonnell joined the Board of Directors in March 2015 following the Company’s acquisition of Allergan, Inc., having served as a member of the Allergan, Inc. Board of Directors from 2013. Dr. McDonnell has been the Director and William Holland Wilmer Professor of the Wilmer Eye Institute of the Johns Hopkins University School of Medicine since 2003. Dr. McDonnell has also served as the Chief Medical Editor of Ophthalmology Times since 2004, and has served on the editorial boards of numerous ophthalmology journals. Dr. McDonnell also served as the Assistant Chief of Service at the Wilmer Institute from 1987 to 1988. Dr. McDonnell also serves as the President and a director of the National Alliance for Eye and Vision Research and the Alliance for Eye and Vision Research and as the Chief Medical Editor of the Ophthalmology Times. He served as a consultant to the United States Department of Health and Human Services in 1996. Dr. McDonnell served as a full-time faculty at the University of Southern California from 1988 until 1999, where he advanced to the rank of professor in 1994.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 449,941
Fiscal Year Total, USD 449,941

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --